Harman Patil (Editor)

Trimetrexate

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
MedlinePlus
  
a694019

Bioavailability
  
VD: 20-30 Liters

Molar mass
  
369.418 g/mol

ATC code
  
P01AX07 (WHO)

Biological half-life
  
11 to 12 hours

CAS ID
  
52128-35-5

Trimetrexate

AHFS/Drugs.com
  
Consumer Drug Information

Metabolism
  
Oxidative O-demethylation, followed by conjugation with glucuronide or sulfate

Trimetrexate is a quinazoline derivative. It is a dihydrofolate reductase inhibitor.

Uses

It has been used with leucovorin in treating pneumocystis pneumonia.

It has been investigated for use in treating leiomyosarcoma. It is a methotrexate (MTX) analog that is active against transport-deficient MTX-resistant tumor cells that overcome the acquired and natural resistance to methotrexate. Other uses include skin lymphoma.

References

Trimetrexate Wikipedia


Similar Topics